Skip to main content

UPDATE 1-Australia's CSL posts 8% rise in H1 profit; raises FY outlook

Australian biotech company CSL Ltd posted an 8% rise in first-half earnings on Wednesday and raised its full-year profit forecast as it benefits from a move to distribute its own products in China.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.